A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2009
11/25/2009	CN101589309A Methods for screening and treatment involving the genes GYPC, AGPAT3, AGL, PVRL2, HMGB3, HSDL2 and/or LDB2
11/25/2009	CN101589056A Depsipeptides and their therapeutic use
11/25/2009	CN101589046A Azaspiro derivatives
11/25/2009	CN101589041A Nitrogen-containing heterocyclic compounds and methods of use thereof
11/25/2009	CN101589037A Heteromonocyclic compound and use thereof
11/25/2009	CN101588807A Use of D-ribose to treat cardiac arrhythmias
11/25/2009	CN101586132A Scutellarin
11/25/2009	CN101586095A In-vitro culture medium of myeloid mesenchyma stem cell and use thereof
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585860A 4',5,6-trimethoxy scutellarin as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585859A Novel scutellarin derivative as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585858A Application of glycosylated puerarin derivate and its combination for preventing and treating cardiovascular and cerebrovascular disease
11/25/2009	CN101585842A Research and control method of impurity B control method in clopidogrel
11/25/2009	CN101585826A Scutellarin
11/25/2009	CN101585779A New crystal form of Agomelatine, preparation method and use thereof
11/25/2009	CN101584853A Earthworm protein polypeptide preparation
11/25/2009	CN101584850A Fruit vinegar ginkgo oral liquid Chinese medicinal composition and preparation method thereof
11/25/2009	CN101584844A Compound Chinese traditional medicine identification method
11/25/2009	CN101584842A Medicament for treating coronary disease, angina pectoris and reducing blood fat, blood sugar, and preparation method thereof
11/25/2009	CN101584833A Pu-er tea ferment soft capsule and production method thereof
11/25/2009	CN101584808A Application of traditional Chinese medicine composition in preparing medicament for reducing level of plasma brain natriuretic peptide precursor N-end segment
11/25/2009	CN101584807A Application of traditional Chinese medicine composition in preparing medicament of insulin sensitizer
11/25/2009	CN101584805A Chinese medicine preparation for treating heart failure
11/25/2009	CN101584799A Medicament for treating angina pectoris
11/25/2009	CN101584793A Pure natural health-care four-Huai medicine
11/25/2009	CN101584774A Application of compound thrombus-invigorating capsule for preparation of medicament for treating cerebrovascular disease
11/25/2009	CN101584769A Novel use of esculin and digitalisglycosides eye drops
11/25/2009	CN101584768A Smouldering washing solution for treating hemorrhoid and preparing method thereof
11/25/2009	CN101584760A Chinese medicinal herb for curing mixed hemorrhoid
11/25/2009	CN101584752A Extraction and purification process for total flavonoids in Anchusa italica Retiz
11/25/2009	CN101584748A Method for preparing shizandra active freeze-dried powder and capsules
11/25/2009	CN101584743A Method for preparing Chinese traditional medicinal compound salvia miltiorrhiza preparation for curing cardiovascular and cerebrovascular diseases
11/25/2009	CN101584742A Traditional Chinese medicine compound for treating hypertension and preparation process thereof
11/25/2009	CN101584730A Injection preparation and quality control method thereof
11/25/2009	CN101584720A Ixers sonchifolia freeze-dried powder for injection and preparation method thereof
11/25/2009	CN101584700A Pharmaceutical composition
11/25/2009	CN101584695A Medicine composition of atorvastatin calcium nicotinic acid
11/25/2009	CN101584686A Application of sodium valproate during preparing medicament for treating retina disease
11/25/2009	CN101584683A Metolazone slow-release capsule and method for preparing same
11/25/2009	CN101584682A Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof
11/25/2009	CN101584655A High-purity salidroside injection preparation and preparation method thereof
11/25/2009	CN101584371A Health-care tea for nourishing yin, clearing away heat and reducing blood glucose for middle-old aged people
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562333C Chinese traditional medicine for creating coronary heart disease and heart angina and the preparation method
11/25/2009	CN100562329C Decompression unction composition and method for producing same
11/24/2009	US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009	US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622449 4-[(2S,3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-4-oxoazetidin-2-yl]phenyl methyl beta -D-glucopyranosiduronate; useful for lowering plasma cholesterol levels, particularly low density lipoprotein, treating and preventing atherosclerosis
11/24/2009	US7622439 Method to enhance hemodynamic stability using oxygen carrying compositions
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2431834C Methods and formulations for the treatment of female sexual dysfunction
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/24/2009	CA2376870C Method for scavenging radicals with urocanic acid, derivatives and analogues
11/19/2009	WO2009140407A1 Maintenance of platelet inhibition during antiplatelet therapy
11/19/2009	WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	WO2009140140A1 Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction
11/19/2009	WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009138802A1 A drilling rig and a method for moving a drilling rig
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138438A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
11/19/2009	WO2009138195A2 Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension
11/19/2009	WO2009138122A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors
11/19/2009	WO2009138035A1 Screening method for medicine of blocking cholesterol absorption based on analyzing subcellular localization of npc1l1 protein
11/19/2009	WO2009120307A3 Method of treating peripheral arterial disease
11/19/2009	WO2009055613A3 Inhibition of urokinase-type plasminogen activator (upa) activity
11/19/2009	US20090287072 Polymer compositions, coatings and devices, and methods of making and using the same
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286958 Interferon-beta fusion proteins and uses
11/19/2009	US20090286883 Treatment of heart failure and associated conditions by administration of monoamine oxidase inhibitors
11/19/2009	US20090286882 Cyclopropylacetic Acid Derivatives and Use Thereof
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286845 Carvedilol phosphate
11/19/2009	US20090286844 Carvedilol phosphate
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286819 Process for Preparing the Calcium Salt of Rosuvastatin
11/19/2009	US20090286813 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
11/19/2009	US20090286800 Glucokinase Activators
11/19/2009	US20090286796 Compounds exhibiting type X sPLA2 inhibiting effect
11/19/2009	US20090286790 Organic compounds
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286781 Use of Suluble Guanylate Cyclase Acitvators for Treating Acute and Chronic Lung Diseases
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009	US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286723 Hybrid Polypeptides with Selectable Properties
11/19/2009	US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009	US20090285911 Cynara scolymus extracts, the use thereof and formulations containing them
11/19/2009	US20090285909 Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof

1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 1595